These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators. Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770 [TBL] [Abstract][Full Text] [Related]
8. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria. Doymaz MZ; Karaaslan E Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061 [No Abstract] [Full Text] [Related]
9. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. McPhee JB; Lewenza S; Hancock RE Mol Microbiol; 2003 Oct; 50(1):205-17. PubMed ID: 14507375 [TBL] [Abstract][Full Text] [Related]
10. Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Macfarlane ELA; Kwasnicka A; Hancock REW Microbiology (Reading); 2000 Oct; 146 ( Pt 10)():2543-2554. PubMed ID: 11021929 [TBL] [Abstract][Full Text] [Related]
11. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741. Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232 [TBL] [Abstract][Full Text] [Related]
13. Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae, São Paulo, Brazil. Bartolleti F; Seco BM; Capuzzo Dos Santos C; Felipe CB; Lemo ME; Alves Tda S; Passadore LF; Mimica MJ; Sampaio SC; Zavascki AP; Sampaio JL Emerg Infect Dis; 2016 Oct; 22(10):1849-51. PubMed ID: 27648951 [No Abstract] [Full Text] [Related]
14. Antimicrobial Activity and Stability of Short and Long Based Arachnid Synthetic Peptides in the Presence of Commercial Antibiotics. Arenas I; Villegas E; Walls O; Barrios H; Rodríguez R; Corzo G Molecules; 2016 Feb; 21(2):. PubMed ID: 26901176 [TBL] [Abstract][Full Text] [Related]
15. Capsule expression in Streptococcus mitis modulates interaction with oral keratinocytes and alters susceptibility to human antimicrobial peptides. Rukke HV; Engen SA; Schenck K; Petersen FC Mol Oral Microbiol; 2016 Aug; 31(4):302-13. PubMed ID: 26255868 [TBL] [Abstract][Full Text] [Related]
16. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430 [TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship study using peptide arrays to optimize Api137 for an increased antimicrobial activity against Pseudomonas aeruginosa. Bluhm ME; Knappe D; Hoffmann R Eur J Med Chem; 2015 Oct; 103():574-82. PubMed ID: 26408816 [TBL] [Abstract][Full Text] [Related]
18. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)]. Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048 [TBL] [Abstract][Full Text] [Related]
19. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860 [TBL] [Abstract][Full Text] [Related]
20. Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins. Hashemi MM; Rovig J; Weber S; Hilton B; Forouzan MM; Savage PB Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]